Company / Financials
Xtant Medical Holdings, Inc. Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$117.3M
FY2025 · +28.4% YoY
Net Income
-$16.4M
FY2025 · -2592.3% YoY
Profit Margin
-14.0%
FY2025 · net income / revenue
ROE
-38.3%
FY2025 · return on equity
Total Assets
$94.1M
FY2025
Total Debt
$11.0M
0.26x debt/equity
Equity
$43.0M
FY2025
ROA
-17.5%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$117.3M+28.4% YoYNet Income HistoryProfit after all expenses and taxes-$16.4M-2592.3% YoYGross Profit HistoryRevenue minus cost of goods sold$68.2M+23.0% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$49.1M+36.9% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$12.1M-18.9% YoYSG&A Expense HistorySelling, general, and administrative expenses$28.7M+11.0% YoYR&D Expense HistoryResearch and development spending$2.4M+78.5% YoYInterest Expense HistoryCost of borrowing and debt obligations$4.2M+41.6% YoYIncome Tax HistoryTotal income tax expense$187.0K+111.0% YoYEPS (Basic) HistoryBasic earnings per share-$0.12-1300.0% YoY